Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- N/A
Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
Standard Treatments of Very-early Stage Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology
- Status
- COMPLETED
- Phase
- N/A
A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
- Status
- COMPLETED
- Phase
- NA
Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1
- Status
- COMPLETED
- Phase
- NA
Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC
- Status
- COMPLETED
- Phase
- PHASE1
Prospective, Multicenter HCCIS Evaluation Study
- Status
- UNKNOWN
- Phase
- N/A
First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Resection+Highly Purified CTL Versus Resection Alone for HCC
- Status
- UNKNOWN
- Phase
- PHASE3
Evaluation of Performance of Automatic Fusion for Radiofrequency Ablation of Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- NA
Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240)
- Status
- COMPLETED
- Phase
- PHASE3